SEOUL: South Korea’s LG Chem said in a regulatory filing on Tuesday (Oct 18) that it is investing US$566 million to acquire US firm Aveo Pharmaceuticals Inc and enter the U.S. anti-cancer drug market.
The deal is expected to close in the first quarter of 2023, LG Chem said.